Wal-Mart Bribery Rumors Churn and 2 Dow Movers Sparking Chatter

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Johnson & Johnson (NYSE:JNJ): Current price $74.29

Research indicates that around 8 million children, or 1 of 20 in the United States, get migraines, but  two studies show that medicines to prevent or treat migraines in adults are not effective in children, according to Bloomberg. An analysis of 21 trials published in JAMA Pediatrics indicated that Johnson and Johnson’s  seizure medicine Topamax and the antidepressant trazodone show limited evidence to support use in children’s migraines occurring fewer than 15 times a month and  that other drugs, among which include some meds for hypertension, are no better than a placebo.


Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business